论文部分内容阅读
目的：研究分析阿托伐他汀治疗冠心病合并高脂血症应用效果。方法：选取本院2014年4月~2015年4月期间收治的冠心病伴高脂血症患者83例，采用数字标注法随机分为观察组与对照组，观察组42例，采用阿托伐他汀胶囊给予治疗，对照组41例，采用血滞通胶囊给予治疗，对比观察两组患者临床疗效。结果：全部患者在治疗4周后血脂各项指标得到明显改善，与治疗前相比差异显著（t=2.3431，P=0.0215）有统计学意义；而在治疗8周后，观察组患者血脂改善效果明显优于对照组，（t=3.0608，P=0.0030）差异有统计学意义。结论：阿托伐他汀治疗冠心病合并高脂血症具有较高疗效，其调节血脂的药用价值较高可有效改善冠心病患者症状，值得临床应用。
Objective: To study the effect of atorvastatin in treating coronary heart disease complicated with hyperlipidemia. Methods: Eighty-three patients with coronary heart disease and hyperlipidemia admitted from April 2014 to April 2015 in our hospital were randomly divided into observation group and control group by digital labeling method. The observation group was treated with atorvastatin Statin capsules were given for treatment, 41 cases in the control group were treated with Xue-Li-Tong Capsule, and the clinical effects were compared between the two groups. Results: After 4 weeks of treatment, the indexes of blood lipids in all patients were significantly improved, with significant difference (t = 2.3431, P = 0.0215) before treatment, and in the observation group after 8 weeks of treatment, the blood lipids were improved The effect was significantly better than the control group (t = 3.0608, P = 0.0030) difference was statistically significant. Conclusion: Atorvastatin is effective in treating coronary heart disease complicated with hyperlipidemia, and its high medicinal value in regulating blood lipid can effectively improve the symptoms of patients with coronary heart disease, which is worthy of clinical application.